【NMPA Update】Medical Device Termination of Registration Review Notices — August 4, 2026

On August 4, 2026, the Center for Medical Device Evaluation of China's National Medical Products Administration (NMPA) released the latest batch of "Medical Device Termination of Registration Review Notice" delivery information. A total of 6 products are covered in this update, spanning both domestic and imported medical devices.

Effective June 1, 2024, applicants can access electronic versions of these documents via the NMPA Government Service Portal — under "My Applications" — and print them directly following the on-screen instructions.

The products subject to termination of registration review in this batch are as follows:

For domestic products: Suzhou Shangke Optical Co., Ltd.'s Soft Hydrophilic Contact Lens (Acceptance No. CQY2601032), and Guangzhou Huarui Medical Device Co., Ltd.'s Anterior Cervical Plate and Screw System (Acceptance No. CQZ2600498).

For imported products: Siemens Healthcare Diagnostics Products GmbH's Fully Automated Protein Analyzer (Acceptance No. JQX2600990), represented by Siemens Medical Diagnostics Products (Shanghai) Co., Ltd.; and B. Braun Melsungen AG's Central Venous Catheter (Acceptance No. JQX2600996), represented by B. Braun Medical (Shanghai) International Trading Co., Ltd.. Additionally, Laboratoires VIVACY's Cross-linked Sodium Hyaluronate Gel for Injection (Acceptance No. JQZ2500042), represented by Tigermed Jetong (Beijing) Pharmaceutical Technology Co., Ltd.; and BIOTEM CO., LTD.'s Dental Implant System (Acceptance No. JQZ2500111), represented by Beijing Maris Trading Co., Ltd., are also included in this batch.

The full notice has been published on the NMPA official website. Affected applicants are advised to log in to the system promptly to access their electronic documents and complete any required follow-up procedures.